Skip to content

Artiva Biotherapeutics, Inc. ARTV Capital investments accrued but not yet paid

Capital investments accrued but not yet paid at other companies

FMC Corporation logo
FMC CorporationFMC
$1.9M-80.4%
APO
Apogee EnterprisesAPOG
$3.2M+216%
Vestis logo
VestisVSTS
$4.2M
HTF
Heartflow, Inc. Common StockHTFL
$912K+15,100%
AMC Networks Inc. logo
AMC Networks Inc.AMCX
$4.37M+169%
Taboola.com Ltd. logo
Taboola.com Ltd.TBLA
$617K-67.4%

Other financials

Income statement

See full
Revenue-
Operating income-$24.4M-10.2%
Net income-$23.5M-15.8%
EPS (diluted)-$0.95-14.5%

Balance sheet

See full
Cash & equivalents$21.4M-30.6%
Total debt$10.3M-26.7%
Total equity$87.8M-48.0%
Total assets$106.0M-44.6%

Cash flow

See full
Operating cash flow-$21.0M-5.6%
CapEx$242.0K-52.6%
Free cash flow-$21.2M-4.1%

Valuation

See full
Market cap$429.03M+1,015%
Enterprise value$417.88M+1,832%

Profitability

See full
Operating margin-83.9%
Net margin-79.3%

Returns & leverage

See full
Return on equity-67.9%
Debt / equity0.1×0.0×
Current ratio8.2×-5.8×

Where this comes from

Reported directly by Artiva Biotherapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CapitalExpendituresIncurredButNotYetPaid.

The official record: Artiva Biotherapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Artiva Biotherapeutics, Inc.'s capital investments accrued but not yet paid.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Artiva Biotherapeutics, Inc.'s capital investments accrued but not yet paid?
Artiva Biotherapeutics, Inc. (ARTV) reported capital investments accrued but not yet paid of $298K in Q1 2026.
How has Artiva Biotherapeutics, Inc.'s capital investments accrued but not yet paid changed year-over-year?
Artiva Biotherapeutics, Inc.'s capital investments accrued but not yet paid decreased by 66.2% year-over-year, from $882K to $298K.